Short Interest in CBD Life Sciences Inc. (OTCMKTS:CBDL) Decreases By 88.3%

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 39,500 shares, a decline of 88.3% from the December 31st total of 338,600 shares. Based on an average daily trading volume, of 75,074,700 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBD Life Sciences stock opened at $0.00 on Wednesday. CBD Life Sciences has a 12-month low of $0.00 and a 12-month high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.